ArticleNature communications2024

Cancer-associated Histone H3 N-terminal arginine mutations disrupt PRC2 activity and impair differentiation.

Benjamin A Nacev et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.